• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可被绿光激活以克服乳腺癌细胞耐药性的阿霉素-NO释放分子杂化物

Doxorubicin-NO Releaser Molecular Hybrid Activatable by Green Light to Overcome Resistance in Breast Cancer Cells.

作者信息

Parisi Cristina, Moret Francesca, Fraix Aurore, Menilli Luca, Failla Mariacristina, Sodano Federica, Conte Claudia, Quaglia Fabiana, Reddi Elena, Sortino Salvatore

机构信息

Department of Drug and Health Sciences, University of Catania, I-95125 Catania, Italy.

Department of Biology, University of Padova, I-35131 Padova, Italy.

出版信息

ACS Omega. 2022 Feb 24;7(9):7452-7459. doi: 10.1021/acsomega.1c03988. eCollection 2022 Mar 8.

DOI:10.1021/acsomega.1c03988
PMID:35284722
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8908524/
Abstract

The biological activity of a molecular hybrid () joining doxorubicin (DOX) and an N-nitroso moiety releasing nitric oxide (NO) under irradiation with the biocompatible green light has been investigated against DOX-sensitive (MCF7) and -resistant (MDA-MB-231) breast cancer cells . shows significantly higher cellular internalization than DOX in both cell lines and, in contrast to DOX, does not experience cell efflux in MDR overexpressing MDA-MB-231 cells. The higher cellular internalization of the hybrid seems to be mediated by bovine serum albumin (BSA) as a suitable carrier among serum proteins, according to the high binding constant measured for , which is more than one order of magnitude larger than that reported for DOX. Despite the higher cellular accumulation, is not toxic in the dark but induces remarkable cell death following photoactivation with green light. This lack of dark toxicity is strictly related to the different cellular compartmentalization of the molecular hybrid that, different from DOX, does not localize in the nucleus but is mainly confined in the Golgi apparatus and endoplasmic reticulum and therefore does not act as a DNA intercalator. The photochemical properties of the hybrid are not affected by binding to BSA as demonstrated by the direct detection of NO photorelease, suggesting that the reduction of cell viability observed under light irradiation is a combined effect of DOX phototoxicity and NO release which, ultimately, inhibits MDR1 efflux pump in DOX-resistant cells.

摘要

一种分子杂化物()的生物活性已在生物相容性绿光照射下进行了研究,该杂化物连接了阿霉素(DOX)和一个在照射下释放一氧化氮(NO)的N-亚硝基部分,其针对对DOX敏感的(MCF7)和耐药的(MDA-MB-231)乳腺癌细胞。在两种细胞系中,该杂化物的细胞内化显著高于DOX,并且与DOX不同,在过表达MDR的MDA-MB-231细胞中不会出现细胞外排。根据所测得的该杂化物的高结合常数,其比报道的DOX的结合常数大一个多数量级,杂化物更高的细胞内化似乎是由牛血清白蛋白(BSA)作为血清蛋白中的合适载体介导的。尽管细胞积累更高,但该杂化物在黑暗中无毒,但在绿光光激活后会诱导显著的细胞死亡。这种黑暗毒性的缺乏与分子杂化物不同的细胞区室化密切相关,与DOX不同,它不在细胞核中定位,而是主要局限于高尔基体和内质网,因此不充当DNA嵌入剂。通过直接检测NO光释放证明,杂化物的光化学性质不受与BSA结合的影响,这表明在光照射下观察到的细胞活力降低是DOX光毒性和NO释放的综合作用,最终抑制了耐药细胞中的MDR1外排泵。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68f9/8908524/fae29ae3b813/ao1c03988_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68f9/8908524/fae29ae3b813/ao1c03988_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68f9/8908524/fae29ae3b813/ao1c03988_0009.jpg

相似文献

1
Doxorubicin-NO Releaser Molecular Hybrid Activatable by Green Light to Overcome Resistance in Breast Cancer Cells.可被绿光激活以克服乳腺癌细胞耐药性的阿霉素-NO释放分子杂化物
ACS Omega. 2022 Feb 24;7(9):7452-7459. doi: 10.1021/acsomega.1c03988. eCollection 2022 Mar 8.
2
Tumor-targeting pH/redox dual-responsive nanosystem epigenetically reverses cancer drug resistance by co-delivering doxorubicin and GCN5 siRNA.肿瘤靶向 pH/氧化还原双重响应纳米系统通过共递送阿霉素和 GCN5 siRNA 表观遗传逆转癌症耐药性。
Acta Biomater. 2021 Nov;135:556-566. doi: 10.1016/j.actbio.2021.09.002. Epub 2021 Sep 5.
3
Glabridin resensitizes p-glycoprotein-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents.甘草素使过度表达 P-糖蛋白的多药耐药癌细胞对常规化疗药物重新敏感。
Eur J Pharmacol. 2019 Jun 5;852:231-243. doi: 10.1016/j.ejphar.2019.04.002. Epub 2019 Apr 5.
4
Light-Regulated NO Release as a Novel Strategy To Overcome Doxorubicin Multidrug Resistance.光调控一氧化氮释放作为克服阿霉素多药耐药性的新策略。
ACS Med Chem Lett. 2017 Jan 30;8(3):361-365. doi: 10.1021/acsmedchemlett.7b00016. eCollection 2017 Mar 9.
5
Selenium Overcomes Doxorubicin Resistance in Their Nano-platforms Against Breast and Colon Cancers.硒在其针对乳腺癌和结肠癌的纳米平台中克服了多柔比星耐药性。
Biol Trace Elem Res. 2020 Feb;193(2):377-389. doi: 10.1007/s12011-019-01730-6. Epub 2019 May 8.
6
Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin.白藜芦醇通过增加阿霉素的细胞内流入量来增强其对多药耐药性人乳腺癌细胞的化学敏感性。
Biochim Biophys Acta. 2014 Jan;1840(1):615-25. doi: 10.1016/j.bbagen.2013.10.023. Epub 2013 Oct 24.
7
Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.增殖诱导基因和增殖抑制基因表达的改变可能导致乳腺癌细胞获得性多柔比星耐药。
Cell Biochem Biophys. 2009;55(2):95-105. doi: 10.1007/s12013-009-9058-3. Epub 2009 Jul 11.
8
Combination Therapy of Doxorubicin and Quercetin on Multidrug-Resistant Breast Cancer and Their Sequential Delivery by Reduction-Sensitive Hyaluronic Acid-Based Conjugate/d-α-Tocopheryl Poly(ethylene glycol) 1000 Succinate Mixed Micelles.多柔比星和槲皮素联合治疗多药耐药乳腺癌及其通过还原敏感的透明质酸基共轭物/d-α-生育酚聚乙二醇 1000 琥珀酸混合胶束的序贯递送。
Mol Pharm. 2020 Apr 6;17(4):1415-1427. doi: 10.1021/acs.molpharmaceut.0c00138. Epub 2020 Mar 20.
9
A new polymer-lipid hybrid nanoparticle system increases cytotoxicity of doxorubicin against multidrug-resistant human breast cancer cells.一种新型聚合物-脂质杂化纳米颗粒系统可增强阿霉素对多药耐药性人乳腺癌细胞的细胞毒性。
Pharm Res. 2006 Jul;23(7):1574-85. doi: 10.1007/s11095-006-0282-x. Epub 2006 Jun 24.
10
Characterization and Evaluation of Bone-Derived Nanoparticles as a Novel pH-Responsive Carrier for Delivery of Doxorubicin into Breast Cancer Cells.骨源性纳米颗粒的特性评估及其作为一种新型 pH 响应性载体用于阿霉素递送入乳腺癌细胞。
Int J Mol Sci. 2020 Sep 14;21(18):6721. doi: 10.3390/ijms21186721.

引用本文的文献

1
Mixed β-γ-Cyclodextrin Branched Polymer with Multiple Photo-Chemotherapeutic Cargos.具有多种光化学治疗药物的混合β-γ-环糊精支化聚合物
ACS Appl Polym Mater. 2023 Aug 31;5(10):7918-7926. doi: 10.1021/acsapm.3c01157. eCollection 2023 Oct 13.
2
A Supramolecular Nanoassembly of Lenvatinib and a Green Light-Activatable NO Releaser for Combined Chemo-Phototherapy.一种用于联合化疗-光疗的乐伐替尼与绿光可激活一氧化氮释放剂的超分子纳米组装体。
Pharmaceutics. 2022 Dec 28;15(1):96. doi: 10.3390/pharmaceutics15010096.

本文引用的文献

1
NO release regulated by doxorubicin as the green light-harvesting antenna.阿霉素作为绿色光捕获天线对一氧化氮释放的调控
Chem Commun (Camb). 2020 Jun 11;56(47):6332-6335. doi: 10.1039/d0cc02512g.
2
Structure-efficiency relationship of photoinduced electron transfer-triggered nitric oxide releasers.光诱导电子转移触发的一氧化氮供体的结构-效率关系。
Sci Rep. 2019 Feb 5;9(1):1430. doi: 10.1038/s41598-018-38252-5.
3
Harnessing albumin as a carrier for cancer therapies.利用白蛋白作为癌症治疗的载体。
Adv Drug Deliv Rev. 2018 May;130:73-89. doi: 10.1016/j.addr.2018.07.011. Epub 2018 Jul 27.
4
Revisiting the role of ABC transporters in multidrug-resistant cancer.重新审视 ABC 转运蛋白在多药耐药性癌症中的作用。
Nat Rev Cancer. 2018 Jul;18(7):452-464. doi: 10.1038/s41568-018-0005-8.
5
Nitric Oxide Donor-Based Cancer Therapy: Advances and Prospects.基于一氧化氮供体的癌症治疗:进展与前景。
J Med Chem. 2017 Sep 28;60(18):7617-7635. doi: 10.1021/acs.jmedchem.6b01672. Epub 2017 May 23.
6
Light-Regulated NO Release as a Novel Strategy To Overcome Doxorubicin Multidrug Resistance.光调控一氧化氮释放作为克服阿霉素多药耐药性的新策略。
ACS Med Chem Lett. 2017 Jan 30;8(3):361-365. doi: 10.1021/acsmedchemlett.7b00016. eCollection 2017 Mar 9.
7
Overcoming multidrug resistance by targeting mitochondria with NO-donating doxorubicins.通过使用可释放一氧化氮的阿霉素靶向线粒体来克服多药耐药性。
Bioorg Med Chem. 2016 Mar 1;24(5):967-75. doi: 10.1016/j.bmc.2016.01.021. Epub 2016 Jan 14.
8
An overview of molecular hybrids in drug discovery.药物研发中分子杂合物概述。
Expert Opin Drug Discov. 2016;11(3):281-305. doi: 10.1517/17460441.2016.1135125. Epub 2016 Jan 12.
9
Differential drug resistance acquisition to doxorubicin and paclitaxel in breast cancer cells.乳腺癌细胞对阿霉素和紫杉醇的药物耐药性差异获得。
Cancer Cell Int. 2014 Dec 21;14(1):142. doi: 10.1186/s12935-014-0142-4. eCollection 2014.
10
Nitric oxide donor doxorubicins accumulate into Doxorubicin-resistant human colon cancer cells inducing cytotoxicity.一氧化氮供体阿霉素可累积进入耐阿霉素的人结肠癌细胞,诱导细胞毒性。
ACS Med Chem Lett. 2011 Apr 4;2(7):494-7. doi: 10.1021/ml100302t. eCollection 2011 Jul 14.